Contact the Editorial Desk

Editorial correspondence

This desk welcomes notes on the record itself: a citation that reads loosely, a trial that has posted new results, a regulatory status that has shifted, or a peer-reviewed study on sermorelin, ipamorelin, CJC-1295, or the combination that belongs on the references page. The most useful message names the page, the exact passage, and the supporting source — a DOI or PubMed identifier wherever available — so a proposed change can be checked before anything is revised.

Editorial mailbox: editors@peptideprosusa.com

What this desk cannot do

Because Peptide Pros USA reports the research literature rather than practicing medicine or selling anything, a few requests fall outside what it can answer:

• Weigh in on or advise human use of any compound covered here.
• Name a dose, schedule, or protocol for any individual.
• Judge whether a finding from a cited trial applies to a specific person's situation.
• Help source, sell, or track down any of the four compounds.
• Guide athletes on anti-doping questions, though it is worth noting all four compounds are WADA-prohibited at all times.

Anyone seeking medical guidance should bring it to a licensed clinician in their own jurisdiction. Replies to editorial notes are not guaranteed and can take time; the mailbox is checked periodically.